Sutro Biopharma Inc (STRO) Receives a Buy from Cowen & Co.

In a report released yesterday, Boris Peaker from Cowen & Co. maintained a Buy rating on Sutro Biopharma Inc (STRO – Research Report). The company’s shares closed on Friday at $11.20. According More »

Analysts Offer Insights on Healthcare Companies: Global Blood Therapeutics (NASDAQ: GBT) and Acceleron Pharma (NASDAQ: XLRN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Global Blood Therapeutics (GBT – Research Report) and Acceleron Pharma (XLRN – Research Report) More »